Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals, people familiar with the matter said, as it seeks to expand its global footprint.
Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals, according to people familiar with the matter.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near Italy
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
More story pages
South Korea triggers KOSPI sidecar mechanism as futures slide 5%
South Korea’s exchange triggers KOSPI sidecar mechanism as KOSPI 200 futures slide 5%.
Ireland finds oldest English poem in Rome book
Researchers in Ireland have discovered the oldest known English-language poem in a forgotten medieval book in Rome.
Cambridge Science Park unveils £3B expansion plan
Cambridge Science Park announces a £3 billion expansion plan, according to the Financial Times.
UK firms halt investments, hiring as Iran war pushes up costs
UK companies halt investments and hiring due to rising costs caused by the Iran conflict, according to business leaders.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.